University Of California, San Francisco

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

A Prospective Analysis of Preoperative Fascia Iliaca Block for Hip Arthroscopy

Phase 4

Completed

Conditions: Pain
Muscle Weakness | Patient

Interventions: Drug: Peripheral Nerve Block
Drug: Sham Block

First Posted Date: 2015-12-07

Last Posted Date: 2018-12-27

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 80

Registration Number: NCT02623361

Locations: 🇺🇸
Orthopedic Institute, San Francisco, California, United States

Women Informed to Screen Depending on Measures of Risk (Wisdom Study)

Not Applicable

Recruiting

Conditions: Breast Cancer Screening
Breast Cancer
Breast Carcinoma in Situ

Interventions: Other: Complete a health questionnaire
Other: Screening advice based on a basic risk assessment
Device: Provide a saliva sample for genetic testing
Other: Screening advice based on a comprehensive risk assessment

First Posted Date: 2015-12-03

Last Posted Date: 2025-04-29

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 100000

Registration Number: NCT02620852

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸
University of California Irvine, Irvine, California, United States
🇺🇸
University of California Los Angeles, Los Angeles, California, United States

and more 8 locations

Livionex Oral Microbiome and Dental Plaque Control in HSCT Recipients

Phase 4

Recruiting

Conditions: Dental Plaque

Interventions: Drug: Livionex® Dental Gel
Drug: PreviDent 5000 plus/Tom's of Maine Children's toothpaste
Device: Kolibree Toothbrush

First Posted Date: 2015-12-01

Last Posted Date: 2024-04-05

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 75

Registration Number: NCT02617407

Locations: 🇺🇸
University of California, San Francisco, California, United States

Mailed FIT Outreach to Improve Colon Cancer Screening in the Safety-net System

Not Applicable

Completed

Conditions: Colonic Neoplasms

Interventions: Behavioral: FIT Outreach

First Posted Date: 2015-11-24

Last Posted Date: 2019-08-09

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 13470

Registration Number: NCT02613260

Locations: 🇺🇸
University of California, San Francisco-San Francisco General Hospital, San Francisco, California, United States

Effect of Clemastine Fumarate on Color Vision in Healthy Controls

Phase 1

Completed

Conditions: Healthy Subjects

Interventions: Drug: Clemastine fumarate

First Posted Date: 2015-11-24

Last Posted Date: 2016-11-03

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 23

Registration Number: NCT02613091

Locations: 🇺🇸
Sandler Neurosciences Building, Neurological Clinical Research Unit, San Francisco, California, United States

CHAMP: A Randomized Controlled Trial of High-intensity Aerobic and Resistance Exercise for Metastatic Prostate Cancer

Not Applicable

Completed

Conditions: Prostate Cancer

First Posted Date: 2015-11-24

Last Posted Date: 2022-08-12

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 28

Registration Number: NCT02613273

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States

Evaluation of Reactive Focal Mass Drug Administration (rfMDA) +/- Reactive Focal Vector Control (RAVC) in Namibia

Phase 3

Completed

Conditions: Malaria

Interventions: Combination Product: RACD
Combination Product: RAVC
Combination Product: rfMDA

First Posted Date: 2015-11-20

Last Posted Date: 2020-07-17

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 9845

Registration Number: NCT02610400

Locations: 🇳🇦
University of Namibia Multidisciplinary Research Centre, Windhoek, Namibia

Clinical Trial of NAC in Asthma

Phase 4

Terminated

Conditions: Asthma

Interventions: Drug: 0.9% saline
Drug: n-acetylcystine

First Posted Date: 2015-11-16

Last Posted Date: 2019-08-20

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 1

Registration Number: NCT02605824

Locations: 🇺🇸
UCSF Airway Clinical Research Center, San Francisco, California, United States

Tas-102 and Radioembolization With 90Y Resin Microspheres for Chemo-refractory Colorectal Liver Metastases

Phase 1

Completed

Conditions: Colon Cancer
Liver Metastases
Rectal Cancer

Interventions: Drug: Tas-102
Device: SIR-Sphere

First Posted Date: 2015-11-11

Last Posted Date: 2022-08-01

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 21

Registration Number: NCT02602327

Locations: 🇺🇸
University of California San Francisco, San Francisco, California, United States

AABM to Decrease Problem Drinking and Impulsivity in Veterans With AUD: A Pilot Study

Not Applicable

Completed

Conditions: Alcohol Use Disorder

Interventions: Behavioral: AABM Training
Behavioral: Sham Training

First Posted Date: 2015-11-09

Last Posted Date: 2024-06-18

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 32

Registration Number: NCT02600832

Locations: 🇺🇸
VA Medical Center San Francisco, San Francisco, California, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy